Development of a Protease-Resistant Reporter to Quantify BCR–ABL Activity in Intact Cells

Analyst, The - United Kingdom
doi 10.1039/c6an01378c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

In Vitro and in Vivo Activity of SKI-606, a Novel SRC-Abl Inhibitor, Against Imatinib-Resistant BCR-Abl+ Neoplastic Cells

Cancer Research
Cancer ResearchOncology
2006English

NPB001-05 Inhibits BCR-Abl Kinase Leading to Apoptosis of Imatinib-Resistant Cells

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

SRC Family Kinases Phosphorylate the BCR-Abl SH3-SH2 Region and Modulate BCR-Abl Transforming Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

A P19Cl6 GFP Reporter Line to Quantify Cardiomyocyte Differentiation of Stem Cells.

International Journal of Developmental Biology
EmbryologyDevelopmental Biology
2004English

Anti-Leukemic Activity of Axitinib Against Cells Harboring the BCR-ABL T315I Point Mutation

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Development of a Potent Protein Degrader Against Oncogenic BCR-ABL Protein

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2019English

Detection of Single Nucleotide Insertion of BCR/ABL Region in Imatinib-Resistant Human Myelogenous Leukemia SR-1 Cells

Experimental & Molecular Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy